Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00645125 · ClinicalTrials.gov registry record · Phase 4
A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT00645125 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 154 participants.
The verdict
NCT00645125, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It is designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
Interventions
- DRUG cefdinir (Omnicef)
- DRUG amoxicillin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2003-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00645125
The ClinicalTrials.gov registry entry for NCT00645125 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cefdinir (Omnicef) is the first listed.
NCT00645125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00645125 about?
NCT00645125 is a clinical study titled "A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications". To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It is designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.
What is the current status of trial NCT00645125?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2003-01.
What interventions are being tested in trial NCT00645125?
The interventions under investigation include: cefdinir (Omnicef) (DRUG), amoxicillin (DRUG).
Who is sponsoring clinical trial NCT00645125?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.